<code id='379506CF1A'></code><style id='379506CF1A'></style>
    • <acronym id='379506CF1A'></acronym>
      <center id='379506CF1A'><center id='379506CF1A'><tfoot id='379506CF1A'></tfoot></center><abbr id='379506CF1A'><dir id='379506CF1A'><tfoot id='379506CF1A'></tfoot><noframes id='379506CF1A'>

    • <optgroup id='379506CF1A'><strike id='379506CF1A'><sup id='379506CF1A'></sup></strike><code id='379506CF1A'></code></optgroup>
        1. <b id='379506CF1A'><label id='379506CF1A'><select id='379506CF1A'><dt id='379506CF1A'><span id='379506CF1A'></span></dt></select></label></b><u id='379506CF1A'></u>
          <i id='379506CF1A'><strike id='379506CF1A'><tt id='379506CF1A'><pre id='379506CF1A'></pre></tt></strike></i>

          hotspot

          hotspot

          author:comprehensive    Page View:852
          accountable care organizations cost saving
          Adobe

          WASHINGTON — A key Obama-era initiative was supposed to save Medicare money by testing new policies for cutting health care costs. It has so far failed to do so, according to nonpartisan congressional budget experts, and it’s not expected to save money anytime soon.

          The 2010 Affordable Care Act created a government center, named the Center for Medicare and Medicaid Innovation, that was given $10 billion over a decade to test new Medicare and Medicaid pay policies. It has since been funded at the same level for another 10 years.

          advertisement

          Republicans have attacked the center over the years. Although most of its pilot programs involve lowering hospital spending, some of the center’s initiatives aiming to lower spending on drugs have often provoked GOP ire. Most recently, they attacked the center’s proposal to cut Medicare pay for drugs that receive accelerated approvals. The Trump administration also used pilot programs to cut drug spending, including its failed attempt to tie Medicare drug payments to prices abroad.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          CRISPR gene editing developments we’re watching in 2024
          CRISPR gene editing developments we’re watching in 2024

          ChristineKao/STATLifeintheCRISPRlanetendstomoveatlightningspeed.Thisyearsawthefirst-everapprovalofam

          read more
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more

          Bristol Myers buys into radiopharmaceuticals with RayzeBio

          CourtesyBristolMyersSquibbBristolMyersSquibbwillpay$4.1billionforRayzeBio,thecompaniessaidTuesday,bu